Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.6K Hold
300
﹤0.01% 1345
2025
Q4
$14.7K Hold
300
﹤0.01% 1339
2025
Q3
$12.9K Sell
300
-112
-27% -$4.38K ﹤0.01% 1384
2025
Q2
$13.9K Buy
412
+128
+45% +$4.89K ﹤0.01% 1236
2025
Q1
$11K Sell
284
-190
-40% -$6.96K ﹤0.01% 1252
2024
Q4
$15.9K Sell
474
-237
-33% -$8.53K ﹤0.01% 1207
2024
Q3
$29.1K Buy
711
+302
+74% +$12.4K ﹤0.01% 1069
2024
Q2
$15.8K Buy
409
+1
+0.2% +$42 ﹤0.01% 1169
2024
Q1
$17.5K Sell
408
-282
-41% -$11.6K ﹤0.01% 1117
2023
Q4
$25.6K Sell
690
-7,416
-91% -$266K ﹤0.01% 970
2023
Q3
$294K Sell
8,106
-2,029
-20% -$72K 0.04% 411
2023
Q2
$361K Buy
10,135
+84
+0.8% +$3.01K 0.05% 345
2023
Q1
$354K Sell
10,051
-2,105
-17% -$73.6K 0.06% 320
2022
Q4
$427K Buy
12,156
+98
+0.8% +$3.26K 0.08% 276
2022
Q3
$355K Buy
+12,058
New +$457K 0.08% 292
2022
Q1
Sell
-4,117
Closed -$233K 467
2021
Q4
$233K Sell
4,117
-4,789
-54% -$249K 0.04% 418
2021
Q3
$444K Hold
8,906
0.08% 274
2021
Q2
$444K Buy
+8,906
New +$428K 0.08% 274
2020
Q1
Sell
-10,232
Closed -$601K 490
2019
Q4
$601K Sell
10,232
-349
-3% -$19.4K 0.06% 277
2019
Q3
$564K Buy
10,581
+6,318
+148% +$325K 0.06% 276
2019
Q2
$213K Buy
+4,263
New +$214K 0.09% 251

Other funds holding GSK

Sunbelt Securities's GSK Position: Q1 2026 in Review

Sunbelt Securities held its GSK (GSK) position steady in Q1 2026 at 300 shares worth $16.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1345.

Sunbelt Securities first reported a position in GSK in Q2 2019 and has held it in 21 quarters since. The position peaked at $601K in Q4 2019. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Sunbelt Securities held 300 shares of GSK worth $16.6K as of Q1 2026.
  • Sunbelt Securities left its GSK share count unchanged in Q1 2026.
  • GSK made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #1345 holding.
  • Sunbelt Securities first reported a position in GSK in Q2 2019 and has held it in 21 quarters since.
  • Sunbelt Securities's GSK position peaked at $601K in Q4 2019.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.